Evivo is the first and only clinically-proven baby probiotic of its kind. Evivo contains the good bacteria B. infantis, which fully utilizes breast milk to protect baby's gut from potentially harmful bacteria linked to higher risk of colic, eczema, allergies, diabetes, and obesity.
12/6/2017 — The bacteria in Evivo, Bifidobacterium longum subsp. infantis (B. infantis) is the critically important bacteria in baby’s gut microbiome early in life. It helps to program metabolism and the immune system and supports the complete digestion of nutrients.
Unfortunately, due to generations of modern medical practices such as antibiotics and C-sections, most babies no longer acquire B. infantis early in life. Without it, potentially harmful bacteria thrive which have been linked to higher risk of colic, eczema, allergies, diabetes, and obesity. To date, probiotics have focused on general gut health and digestion, but until now had not demonstrated the ability to reduce potentially harmful bacteria.
In a controlled clinical trial led by University of California, Davis Medical Center, breastfed babies were given Evivo (activated B. infantis EVC001) once a day and compared to a similar group of babies who did not receive Evivo. This study showed the first-ever restoration of the baby gut microbiome via Evivo. Babies given Evivo saw a 79% increase in bifidobacteria. These Evivo babies also experienced an unprecedented 80% reduction of groups of potentially harmful bacteria such as E. coli, clostridia, Staphylococcus (Staph), and Streptococcus (Strep), which have been linked to disease later in life. Finally, across all babies in the study, those high in bifidobacteria had four times lower levels of endotoxin, a compound known to cause inflammation.
In summary, providing Evivo to babies in this clinical study completely restored the naturally protective gut microbiome in 100% of breastfed babies and significantly reduced potentially harmful groups of bacteria compared to babies who didn’t receive Evivo.
To read this article in full:
5/30/2017 — One key beneficial bacteria is designed by nature to live in babies’ gut, and thrive in the presence of human breast milk: Bifidobacterium (including B. infantis). In fact, the higher the levels of Bifidobacterium in baby’s gut early in life reduces the amount of potentially harmful bacteria which are linked later in life to a higher risk of many conditions like colic, eczema, allergies, diabetes, and obesity. In this recent clinical trial led by The University of California, breast fed babies were given Evivo (activated B. infantis) once a day for a month and were compared to breast fedbabies who didn’t receive any probiotic. After a month, Evivo babies had significantly higher levels of total Bifidobacterium in their gut compared to babies who didn’t receive Evivo. This once-daily probiotic is clinically proven to restore Bifidobacterium to baby’s gut and reduce the amount of potentially harmful bacteria. It’s the first and only baby probiotic of its kind to help establish the foundation of lifelong well-being.
Get the latest updates.
More Media Coverage...
Human Milk Oligosaccharides (HMOs) are special carbohydrates that are food for baby’s gut bacteria. One key beneficial bacteria, B. infantis, is unique and able to capture all these carbohydrates that might otherwise be wasted, consuming them fully allowing B. infantis to grow and protect baby’s gut, and convert them into essential nutrients that are critical for baby’s developing metabolism and immune system.
Probiotics are ‘good’ bacteria that help keep your gut microbiome healthy. Historically, probiotics have been taken with the hope to relieve symptoms such as gas, bloating, or other digestive issues. However, new research has found that gut health is connected to other conditions such as colic, eczema, allergies, diabetes, and obesity and may have a much larger impact on overall health, beyond only symptomatic relief.
Prebiotics are carbohydrates that cannot be digested by the human body. Instead, they are ‘food’ for the gut microbiome. For babies, the most important prebiotics are found in breast milk and are called Human Milk Oligosaccharides (HMOs). HMOs are the third most abundant nutrient in breast milk and are critical to ‘feed’ good bacteria in baby’s gut.
A gut microbiome is a collection of trillions of microorganisms, or bacteria, that live in our intestines, or gut.
By nature’s design, beneficial and protective bacteria are passed from mom to baby during the birthing process, creating baby’s unique gut microbiome. However, the unintended consequences of modern medical practices such as antibiotics, c-sections, and formula feeding have led to a decrease in this mom to baby transfer.
In collaboration with the University of California Medical Center, we completed a clinical trial in which breast fed babies were given Evivo once a day for a month and were compared to breast fed babies who didn’t receive any probiotic. After a month, Evivo babies had significantly higher levels of the key good bacteria, B. infantis, in their gut compared to babies who didn’t receive any Evivo. This good bacteria is critical for proper immune system and metabolic development during the first six months of life.